Keep Us Strong WikiLeaks logo

Currently released so far... 64621 / 251,287

Articles

Browse latest releases

Browse by creation date

Browse by origin

A B C D F G H I J K L M N O P Q R S T U V W Y Z

Browse by tag

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Browse by classification

Community resources

courage is contagious

Viewing cable 06BRASILIA2458, APPROVAL OF NIH RESEARCH PROJECT ENTITLED "TARGETED

If you are new to these pages, please read an introduction on the structure of a cable as well as how to discuss them with others. See also the FAQs
Reference ID Created Released Classification Origin
06BRASILIA2458 2006-11-21 18:53 2011-07-11 00:00 UNCLASSIFIED Embassy Brasilia
VZCZCXYZ0011
RR RUEHWEB

DE RUEHBR #2458 3251853
ZNR UUUUU ZZH
R 211853Z NOV 06
FM AMEMBASSY BRASILIA
TO SECSTATE WASHDC 7444
UNCLAS BRASILIA 002458 
 
SIPDIS 
 
SIPDIS 
 
STATE PASS TO DHHS/NIH/FIC FOR KEVIN BIALY 
 
E.O. 12958: N/A 
TAGS: TBIO KSCA OSCI BR
SUBJECT: APPROVAL OF NIH RESEARCH PROJECT ENTITLED "TARGETED 
THERAPHY FOR BURKITT LYMPHOMA IN RESOURCE POOR SETTING" 
 
REF: BRASILIA 1880 
 
1.  On November 16, 2006, Embassy received from the Brazilian 
Ministry of Foreign Affairs, Division of Science and Technology 
(DCTEC/MFA) an official notification (number 56, dated November 16, 
2006) approving the research project proposal titled "Targeted 
Therapy for Burkitt Lymphoma in Resource Poor Settings", (number CA 
121935-01), under the direction of Dr. Carlos Brites Alves, Dr. Jose 
Henrique Silva Barreto, Dr. Iguaracyra Barreto de Oliveira Araujo, 
from the Federal University of Bahia. Informal translation of the 
approval notice follows: 
 
Begin text: 
 
"This is to inform that after consultation to the appropriate 
federal organs, the project titled "Targeted Therapy for Burkitt 
Lymphoma in Resource Poor Settings," to be developed by the 
principal investigator Dr. Carlos Roberto Brites Alves, from the 
Universidade Federal da Bahia (UFBA), Dr. Jose Henrique Silva 
Barreto and Dr. Iguaracyra Barreto de Oliveira Araujo, these last 
two only considered as investigators, financially supported by the 
National Institutes of Health (NIH), was approved by the Brazilian 
Government. 
 
2) I emphasize that for the collection and transfer of data and/or 
biological material abroad, procedures should conform to current 
legislation. 
 
Cordially, 
(signature) 
Everton Frask Lucero 
Head of the Division of Science and Technology" 
 
End of text of translation. 
 
2.  The Embassy sees no adverse foreign policy implications with 
respect to this research project.  We reiterate the importance of 
complying with Brazilian law on the export of data and biological 
material and medical research involving human beings. 
 
CHICOLA